Christoph Bartenhagen
Overview
Explore the profile of Christoph Bartenhagen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
1262
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen Z, Inague A, Kaushal K, Fazeli G, Schilling D, Xavier da Silva T, et al.
Mol Cell
. 2024 Nov;
84(23):4645-4659.e9.
PMID: 39547224
Selenocysteine (Sec) metabolism is crucial for cellular function and ferroptosis prevention and begins with the uptake of the Sec carrier, selenoprotein P (SELENOP). Following uptake, Sec released from SELENOP is...
2.
Thombare K, Vaid R, Pucci P, Ihrmark Lundberg K, Ayyalusamy R, Baig M, et al.
EMBO J
. 2024 Nov;
43(24):6310-6335.
PMID: 39528654
Neuroblastoma (NB) is the most common extracranial childhood cancer, caused by the improper differentiation of developing trunk neural crest cells (tNCC) in the sympathetic nervous system. The N-methyladenosine (mA) epitranscriptomic...
3.
Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, et al.
J Clin Oncol
. 2024 Sep;
43(2):214-225.
PMID: 39348606
Purpose: The clinical course of pulmonary carcinoids ranges from indolent to fatal disease, suggesting that specific molecular alterations drive progression toward the fully malignant state. A similar spectrum of clinical...
4.
Chen Z, Inague A, Kaushal K, Fazeli G, Xavier da Silva T, Dos Santos A, et al.
bioRxiv
. 2024 Jun;
PMID: 38895225
Selenocysteine (Sec) metabolism is crucial for cellular function and ferroptosis prevention and has traditionally been thought to begin with the uptake of the Sec carrier selenoprotein P (SELENOP). Following uptake,...
5.
Vaid R, Thombare K, Mendez A, Burgos-Panadero R, Djos A, Jachimowicz D, et al.
Nucleic Acids Res
. 2024 Jan;
52(5):2648-2671.
PMID: 38180812
Telomerase-negative tumors maintain telomere length by alternative lengthening of telomeres (ALT), but the underlying mechanism behind ALT remains poorly understood. A proportion of aggressive neuroblastoma (NB), particularly relapsed tumors, are...
6.
Malchers F, Nogova L, van Attekum M, Maas L, Bragelmann J, Bartenhagen C, et al.
J Clin Invest
. 2023 Aug;
133(21).
PMID: 37606995
The discovery of frequent 8p11-p12 amplifications in squamous cell lung cancer (SQLC) has fueled hopes that FGFR1, located inside this amplicon, might be a therapeutic target. In a clinical trial,...
7.
Alborzinia H, Chen Z, Yildiz U, Porto Freitas F, Vogel F, Varga J, et al.
EMBO Mol Med
. 2023 Jul;
15(8):e18014.
PMID: 37435859
Ferroptosis has emerged as an attractive strategy in cancer therapy. Understanding the operational networks regulating ferroptosis may unravel vulnerabilities that could be harnessed for therapeutic benefit. Using CRISPR-activation screens in...
8.
Rosswog C, Fassunke J, Ernst A, Schomig-Markiefka B, Merkelbach-Bruse S, Bartenhagen C, et al.
Br J Cancer
. 2023 Feb;
128(8):1559-1571.
PMID: 36807339
Background: Genomic alterations of the anaplastic lymphoma kinase gene (ALK) occur recurrently in neuroblastoma, a pediatric malignancy of the sympathetic nervous system. However, information on their development over time has...
9.
Meeser A, Bartenhagen C, Werr L, Hellmann A, Kahlert Y, Hemstedt N, et al.
Cell Biosci
. 2022 Sep;
12(1):160.
PMID: 36153564
Background: Telomere maintenance mechanisms (TMM) are a hallmark of high-risk neuroblastoma, and are conferred by activation of telomerase or alternative lengthening of telomeres (ALT). However, detection of TMM is not...
10.
Fischer-Mertens J, Otte F, Roderwieser A, Rosswog C, Kahlert Y, Werr L, et al.
Cell Oncol (Dordr)
. 2022 Aug;
45(5):991-1003.
PMID: 35953764
Background: The majority of high-risk neuroblastomas harbor telomerase activity, and telomerase-interacting compounds, such as 6-thio-2'-deoxyguanosine (6-thio-dG), have been found to impair the growth of telomerase-positive neuroblastoma cell lines. It has...